These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comment on letter of Obermiller and Tzamaloukas [1988 Clin Nephrol 30: 287]. Pollak R; Maddux MS; Cohan J; Jacobsson PK; Mozes MF Clin Nephrol; 1989 Feb; 31(2):118. PubMed ID: 2646051 [No Abstract] [Full Text] [Related]
23. Erythropoietin, interleukin-3, interleukin-11, and GM-CSF in posttransplant erythrocytosis treated with enalapril. Hu RH; Lee PH; Lee CJ Transplant Proc; 1996 Jun; 28(3):1545-7. PubMed ID: 8658779 [No Abstract] [Full Text] [Related]
24. Long-term normalization of resistant renal hypertension after embolization of host kidneys in a transplanted patient--a case report. Bonomini V; Campieri C; Mignani R; Stagni B; Vangelista A Transplantation; 1987 Mar; 43(3):451. PubMed ID: 3547803 [No Abstract] [Full Text] [Related]
25. [Thromboembolism risk factors in kidney transplant patients with secondary erythrocytosis in relation to hemorheologic aspects]. Koall W; Schäbitz J; Kunsch R; Nilius R Z Gesamte Inn Med; 1988 Sep; 43(17):474-7. PubMed ID: 3070972 [TBL] [Abstract][Full Text] [Related]
27. Transient glomerulonephropathy associated with primary erythrocytosis in a dog. Page RL; Stiff ME; McEntee MC; Walter LG J Am Vet Med Assoc; 1990 Feb; 196(4):620-2. PubMed ID: 2303386 [TBL] [Abstract][Full Text] [Related]
29. Erythrocytosis after renal transplantation: risk factors and relationship with GFR. Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630 [TBL] [Abstract][Full Text] [Related]
30. Principia of cancer therapy. IV. Induction of hemoconcentration for phlebotomy in polycythemia vera. Okuyama S; Mishina H; Ito Y; Matsuzawa T Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):29-30. PubMed ID: 6678498 [No Abstract] [Full Text] [Related]
31. Successful treatment of post-renal transplant erythrocytosis with enalapril. Rostaing L; Boisseau M; Durand D; Huyn A; Lloveras JJ; Suc JM Transplant Proc; 1993 Jun; 25(3):2325-6. PubMed ID: 8516915 [No Abstract] [Full Text] [Related]
32. Erythrocytosis after renal transplantation. A prospective analysis. Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681 [TBL] [Abstract][Full Text] [Related]
33. [Impairment of the process of oxygen utilization by tissues in hereditary erythrocytosis]. Dmitrieva MG; Gazenko LO; Poliakova LA; Efimova NK; Krekhnov BV Dokl Akad Nauk SSSR; 1986; 286(5):1276-80. PubMed ID: 3948686 [No Abstract] [Full Text] [Related]
37. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft. Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809 [No Abstract] [Full Text] [Related]
38. Preventive effect of enalapril on erythrocytosis after renal transplantation. Rhee SR; Park SK; Kang SK; Kim SH; Cho BH; Kim JH Transplant Proc; 1996 Jun; 28(3):1555-6. PubMed ID: 8658783 [No Abstract] [Full Text] [Related]
39. [Development of renal function in the transplanted patient with renal hypertension treated with enalapril]. Guerin C; Genin C; Sabatier JC; Toulon J; Leroy G; Berthoux F Nephrologie; 1987; 8(1):19-22. PubMed ID: 3035397 [TBL] [Abstract][Full Text] [Related]
40. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis. Hernández E; Morales JM; Andrés A; Ortuño B; Praga M; Alcazar JM; Fernández G; Rodicio JL Transplant Proc; 1995 Aug; 27(4):2239-41. PubMed ID: 7652789 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]